BTB Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $8.9M (Form D filed Dec 1, 2025; amended Aug 12, 2026). SEC Form D 0002055053-25-000003 (Dec 1, 2025)
  Evidence (1 event)

  • Dec 1, 2025 · SEC Form D 0002055053-25-000003
    Name of Issuer: BTB Therapeutics, Inc.; CIK: 2055053; Address: Escondido, CA; Submission type: D; Filing date: 2025-12-01; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 7402704; Total Amount Sold: 3402704; Federal exemptions: 06b || Name of Issuer: BTB Therapeutics, Inc.; CIK: 2055053; Address: Escondido, CA; Submission type: D/A; Filing date: 2026-08-12; Industry Group: Pharmaceuticals; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10402704; Total Amount Sold: 8902204; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals